Oncology Venture reshuffle: name changes, CFO departure and former minister on (the) board
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12428042.ece/ALTERNATES/schema-16_9/20160224-025712-pf-1920x1080we.jpg)
The Danish biotech company Oncology Venture is certainly experiencing winds of change. Listed on the Swedish stock exchange, it develops precision pharmaceuticals directed at cancer diseases.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.